<p>(<b>A</b>) Morphologies of A549 and A549/DDP cells. Cells were grown to 70% confluency and then photographe under 40× magnification. (<b>B</b>) The IC<sub>50</sub> value of cisplatin to A549/DDP cells was significantly higher than that to A549 cells. (<b>C</b>) Flow cytometric analysis of cell cycle distribution in A549 and A549/DDP cells. (<b>D</b>) The colony formation of A549 and A549/DDP cells treated with various concentrations of cisplatin (0.5, 1.0, 1.5 and 2.0 μg/L). (<b>E</b>) qRT-PCR analysis of HOTAIR expression in A549/DDP and A549 cells. (<b>F</b>) A549 cells were cultured in the presence of various concentrations of cisplatin (0.0, 0.5, 1.0, 1.5 or 2.0 μg/L) for 24h. qRT-PCR assay was performed to detect HOTAIR expression. ...
<p><b>A</b>, Relative HOTAIR expression levels in gastric cancer cell lines were analyzed by qRT-PCR...
Cisplatin is a platinum-based drug that is used for the treatment of a wide-variety of primary human...
Inherent and acquired cisplatin resistance reduces the effectiveness of this agent in the management...
<p>(<b>A</b>) qRT-PCR detection of HOTAIR expression in A549 cells stably transfected with pcDNA/con...
<p>(<b>A</b>) 48h after A549/DDP cells transfected with siRNA/control, siRNA/HOTAIR1 or siRNA/HOTAIR...
<p>(<b>A</b>) Tumor volume was calculated twice weekly following injection of A549/DDP cells transfe...
<p>(<b>A</b>) Western blot analysis of the effect of HOTAIR on p21 protein expression in pcDNA/HOTAI...
<p>(<b>A</b>) 48h after A549/DDP cells transfected with siRNA/control, siRNA/HOTAIR1 alone or combin...
<p>(<b>A</b>) qRT-PCR detection of HOTAIR expression in cisplatin-sensitive (n=21) or insensitve (n=...
<p><b>(A, B)</b> A549Pt and A549cisR cells were plated in 24-well plates and grown for 24 hours, the...
HOTAIR, a long intervening non-coding RNA (lincRNA), associates with the Polycomb Repressive Complex...
HOTAIR, a long intervening non-coding RNA (lincRNA), associates with the Polycomb Repressive Complex...
<div><p>HOTAIR, a long intervening non-coding RNA (lincRNA), associates with the Polycomb Repressive...
<p>(<b>A</b>) CNE2 and HONE1 stable cell lines were treated with 0 or 2.0 μg/ml cisplatin. The MTT a...
<p>Parent and Cisplatin resistant NSCLC cells were treated with cisplatin for 24 h. Cell cycle distr...
<p><b>A</b>, Relative HOTAIR expression levels in gastric cancer cell lines were analyzed by qRT-PCR...
Cisplatin is a platinum-based drug that is used for the treatment of a wide-variety of primary human...
Inherent and acquired cisplatin resistance reduces the effectiveness of this agent in the management...
<p>(<b>A</b>) qRT-PCR detection of HOTAIR expression in A549 cells stably transfected with pcDNA/con...
<p>(<b>A</b>) 48h after A549/DDP cells transfected with siRNA/control, siRNA/HOTAIR1 or siRNA/HOTAIR...
<p>(<b>A</b>) Tumor volume was calculated twice weekly following injection of A549/DDP cells transfe...
<p>(<b>A</b>) Western blot analysis of the effect of HOTAIR on p21 protein expression in pcDNA/HOTAI...
<p>(<b>A</b>) 48h after A549/DDP cells transfected with siRNA/control, siRNA/HOTAIR1 alone or combin...
<p>(<b>A</b>) qRT-PCR detection of HOTAIR expression in cisplatin-sensitive (n=21) or insensitve (n=...
<p><b>(A, B)</b> A549Pt and A549cisR cells were plated in 24-well plates and grown for 24 hours, the...
HOTAIR, a long intervening non-coding RNA (lincRNA), associates with the Polycomb Repressive Complex...
HOTAIR, a long intervening non-coding RNA (lincRNA), associates with the Polycomb Repressive Complex...
<div><p>HOTAIR, a long intervening non-coding RNA (lincRNA), associates with the Polycomb Repressive...
<p>(<b>A</b>) CNE2 and HONE1 stable cell lines were treated with 0 or 2.0 μg/ml cisplatin. The MTT a...
<p>Parent and Cisplatin resistant NSCLC cells were treated with cisplatin for 24 h. Cell cycle distr...
<p><b>A</b>, Relative HOTAIR expression levels in gastric cancer cell lines were analyzed by qRT-PCR...
Cisplatin is a platinum-based drug that is used for the treatment of a wide-variety of primary human...
Inherent and acquired cisplatin resistance reduces the effectiveness of this agent in the management...